1-2 of 2
Debra Bergstrom, BSc, MD FRCPC
Close
Sort by
Journal Articles

Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Christine Chen, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Richard LeBlanc, MD, Heather J. Sutherland, MD PhD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MDFRCP-C, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Nizar J. Bahlis, MD
Journal: Blood
Blood (2016) 128 (22): 3330.
https://doi.org/10.1182/blood.V128.22.3330.3330
Published: 2016
Journal Articles

Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

Nizar J. Bahlis, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Heather J. Sutherland, MD PhD, Richard LeBlanc, MD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MD FRCPC, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Christine Chen, MD
Journal: Blood
Blood (2016) 128 (22): 977.
https://doi.org/10.1182/blood.V128.22.977.977
Published: 2016